Skip to content
User

Bill Miller

Miller Value Partners

Bill Miller CVS Health Corp stake

total: 463

Miller Value Partners CVS trades

Total transactions:
6
New positions:
2
Sold out:
2
Added:
1
Reduced:
1
Held since:
2020 Q3
Held for:
2 quarters
Latest activity:
2021 Q1
According to 2026 Q2 report, Bill Miller doesn't hold any CVS Health Corp (CVS) shares. To date, the estimated cost basis is nearly $61.21 for "buy" trades and estimated average "sell" price is $68.46. Miller Value Partners first purchased CVS in 2019 Q2, initially acquiring 759,575 shares. Bill Miller later completely sold out the position and invested in CVS Health Corp again in 2020 Q3. Since the initial investment in CVS Health Corp (CVS), Miller Value Partners has made 5 more transactions.

When did Bill Miller sell CVS Health Corp (CVS)?

Bill Miller sold off the entire CVS Health Corp (CVS) position in 2021 Q1.

When did Bill Miller buy CVS Health Corp (CVS)?

Bill Miller first invested in CVS Health Corp (CVS) in 2019 Q2 at the reported quarter-end price of $54.49 per share.

What's the cost basis of Miller Value Partners's CVS stake?

The estimated cost basis for CVS Health Corp (CVS) stake is around $61.21 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$61.21
Weighted AVG sell price:
$68.46

Bill Miller's historical trades in CVS Health Corp

6 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2021 Q1
0.00%
0
$68.46
-100% (-1,899)
-0%
2020 Q4
0.00%
$68.46
+40.15% (+544)
2020 Q3
0.00%
$58.30
new
2020 Q1
0.00%
$74.29
-100% (-759,225)
2019 Q4
2.01%
$74.29
-0.05% (-350)
2019 Q2
1.65%
$54.49
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.